Picture of Stayble Therapeutics AB logo

STABL Stayble Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Stayble Therapeutics Appoints Erik Kullgren As CFO

July 23 (Reuters) - Stayble Therapeutics AB  STABL.ST :
    * ERIK KULLGREN HAS BEEN APPOINTED AS NEW CFO WITH EFFECT
FROM 1
AUGUST 2024

Source text for Eikon:  ID:nWkr1q9cyx 
Further company coverage:  STABL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

Recent news on Stayble Therapeutics AB

See all news